Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Simeon George | Director | 2024-03-27 | 451,659 | $10.00 | $4.52MBuy |
Simeon George | Director | 2024-03-27 | 1,548,341 | $10.00 | $15.48MBuy |
Ra Capital Management LP | Director | 2024-03-27 | 3,000,000 | $10.00 | $30.00MBuy |
Paul J. Hastings | Chief Executive Officer | 2024-03-04 | 137,642 | $13.33 | $1.83MSell |
Ralph Brandenberger | Chief Technical Officer | 2024-03-01 | 8,367 | $12.51 | $104.67kSell |
Paul J. Hastings | Chief Executive Officer | 2024-03-01 | 12,358 | $13.00 | $160.65kSell |
Ralph Brandenberger | Chief Technical Officer | 2024-03-01 | 2,955 | $3.89 | $11.49kBuy |
Ralph Brandenberger | Chief Technical Officer | 2024-03-01 | 3,808 | $3.89 | $14.81kBuy |
James Trager | Chief Scientific Officer | 2024-02-12 | 4,143 | $12.00 | $49.72kSell |
Paul J. Hastings | Chief Executive Officer | 2024-01-16 | 9,697 | $8.74 | $84.75kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ra Capital Management LP | 15.79% | 7,805,129 | $59.01M | Institution |
Simeon George | 8.09% | 3,999,999 | $30.24M | Insider |
Nea Management Company LLC | 7.22% | 3,568,781 | $26.98M | Institution |
Adage Capital Partners GP LLC | 6.98% | 3,450,000 | $26.08M | Institution |
Deerfield Management Company LP Series C | 6.88% | 3,400,000 | $25.70M | Institution |
Glaxosmithkline PLC | 6.38% | 3,150,732 | $23.82M | Insider |
New Enterprise Associates 15 LP | 5.87% | 2,902,115 | $21.94M | Insider |
Joshua Makower | 5.87% | 2,902,115 | $21.94M | Insider |
Peter W. Sonsini | 5.87% | 2,902,115 | $21.94M | Insider |
Anthony A. Florence Jr. | 5.87% | 2,902,115 | $21.94M | Insider |